檢索結果 - Elizabeth Ahern

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Factors that influence clinical trial participation for oncology patients in Australia: a scoping review 由 Zarnie Lwin, David Wyld, Elizabeth Ahern, Natasha Roberts, Kyung Ha You

    發表在 BMJ Open (2025-06-01)
    獲取全文
    Article


  2. 2

    Factors that influence clinical trial participation by patients with cancer in Australia: a scoping review protocol 由 Zarnie Lwin, David Wyld, Elizabeth Ahern, Natasha Roberts, Kyung Ha You

    發表在 BMJ Open (2022-04-01)
    獲取全文
    Article


  3. 3

    Neoadjuvant immunotherapy for non-small cell lung cancer: right drugs, right patient, right time? 由 Nick Pavlakis, Ken O'Byrne, Elizabeth Ahern, Brett G M Hughes, Ben J Solomon, Rina Hui

    發表在 Journal for ImmunoTherapy of Cancer (2021-06-01)
    獲取全文
    Article


  4. 4

    Semiqualitative research protocol to explore cancer care workforce perceptions of the health system response to COVID-19 preparations in Southeast Queensland, Australia 由 Zarnie Lwin, David Wyld, Elizabeth Ahern, Brett Hughes, Natasha Roberts, Melissa Eastgate, Harry Gasper, Bryan Chan, Glen Kennedy

    發表在 BMJ Open (2021-05-01)
    獲取全文
    Article


  5. 5

    Rapid Protocol Development, Study Startup and Enrolment of a Prospective Study of COVID-19 Vaccination for Patients with Cancer: A Collaborative Approach 由 Amy Body, Vivienne Milch, Lynda McSorley, Luxi Lal, Elizabeth Ahern, Regina Ryan, Gayle Jones, Dorothy Keefe, Eva Segelov

    發表在 Vaccines (2022-11-01)
    獲取全文
    Article


  6. 6

    An observational study of concomitant immunotherapies and denosumab in patients with advanced melanoma or lung cancer 由 Alexander Liede, Rohini K. Hernandez, Sally W. Wade, Ronghai Bo, Nathan C. Nussbaum, Elizabeth Ahern, William C. Dougall, Mark J. Smyth

    發表在 OncoImmunology (2018-12-01)
    獲取全文
    Article


  7. 7

    717 A phase 1/2 study of AU-007, a monoclonal antibody (mAb) that binds to IL-2 and inhibits CD25 binding, in patients with advanced solid tumors: interim results from dose escalat... 由 Andrew Haydon, John Powderly, Timothy Wyant, James Vasselli, Drew Rasco, Meredith McKean, Elizabeth Ahern, Sophia Frentzas, Andrew Weickhardt, Inbar Amit, Aron Knickerbocker, Yanay Ofran, Paul de Souza, Jenny Tang, Lori Richards

    發表在 Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  8. 8

    Beyond standard data collection – the promise and potential of BRAIN (Brain tumour Registry Australia INnovation and translation registry) 由 Lucy Gately, Katharine Drummond, Mark Rosenthal, Rosemary Harrup, Anthony Dowling, Andrew Gogos, Zarnie Lwin, Ian Collins, David Campbell, Elizabeth Ahern, Claire Phillips, Hui K. Gan, Iwan Bennett, Oliver M. Sieber, Peter Gibbs

    發表在 BMC Cancer (2022-06-01)
    獲取全文
    Article


  9. 9

    Corrigendum: Translatability of findings from cynomolgus monkey to human suggests a mechanistic role for IL-21 in promoting immunogenicity to an anti-PD-1/IL-21 mutein fusion prote... 由 Mark A. Kroenke, Marta Starcevic Manning, Christina L. Zuch de Zafra, Xinwen Zhang, Kevin D. Cook, Michael Archer, Martijn P. Lolkema, Jin Wang, Sarah Hoofring, Gurleen Saini, Famke Aeffner, Elizabeth Ahern, Elena Garralda Cabanas, Ramaswamy Govindan, Mun Hui, Shalini Gupta, Daniel T. Mytych

    發表在 Frontiers in Immunology (2024-06-01)
    獲取全文
    Article


  10. 10

    Translatability of findings from cynomolgus monkey to human suggests a mechanistic role for IL-21 in promoting immunogenicity to an anti-PD-1/IL-21 mutein fusion protein 由 Mark A. Kroenke, Marta Starcevic Manning, Christina L. Zuch de Zafra, Xinwen Zhang, Kevin D. Cook, Michael Archer, Martijn P. Lolkema, Jin Wang, Sarah Hoofring, Gurleen Saini, Famke Aeffner, Elizabeth Ahern, Elena Garralda Cabanas, Ramaswamy Govindan, Mun Hui, Shalini Gupta, Daniel T. Mytych

    發表在 Frontiers in Immunology (2024-01-01)
    獲取全文
    Article


檢索工具: